▼ SELL
10b5-1 Plan
$ Value
$463K
Shares
3,000
Price
$154
Filed
Feb 18
Insider
Name
Dickinson Andrew D
Title
Chief Financial Officer
CIK
0001310204
Roles
Officer
Transaction Details
Transaction Date
2026-02-17
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
167,779
Footnotes
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024. | Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
Filing Info
Dickinson Andrew D's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-15 | GILD | ▼ | $423K |
| 2026-02-27 | GILD | A | $0 |
| 2026-02-17 | GILD | ▼ | $463K |
| 2026-02-03 | GILD | A | $0 |
| 2026-02-03 | GILD | F | $3.6M |
| 2026-01-15 | GILD | ▼ | $373K |
| 2025-12-15 | GILD | ▼ | $366K |
| 2025-12-10 | GILD | M | — |
| 2025-12-10 | GILD | F | $212K |
| 2025-12-10 | GILD | M | — |
Other Insiders at GILD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Dickinson Andrew D
Chief Financial Officer
|
— | — | 2026-02-27 |
|
Dickinson Andrew D / Mercier Johanna
Chief Financial Officer
|
— | $423K | 2026-04-15 |
|
O'Day Daniel Patrick
Chairman & CEO
|
— | $37.2M | 2026-03-27 |
|
Berger Dietmar
Chief Medical Officer
|
— | — | 2026-02-27 |
|
Mercier Johanna
Chief Comm & Corp Aff Officer
|
— | $4.3M | 2026-02-27 |
|
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
|
— | — | 2026-02-27 |